Top Dallas, TX Pharmaceutical Companies (21)
Don't see your company?
Create a company profile
We view pets and pet parents as family and are obsessed with meeting their needs and exceeding customer expectations through every interaction. Behind the scenes, our talented teams are made up of innovators, delighters, big-thinkers and of course, passionate pet people—creating a place where you'll be empowered to build, grow and unleash your fullest potential. We don’t just stand by our company mission—we’re obsessed with it. We seek to be the most trusted and convenient destination for pet parents and partners, everywhere. And we’re constantly finding new ways to do just that. At Chewy, we understand pet parenthood is full of joyful highs and anxious lows. That’s why we’re here, standing alongside pet parents, providing everything their pets need for a happy, healthy life. We’re a leading online source for pet products, supplies, and prescriptions. We offer a broad selection of high-quality products and services at competitive prices with an exceptional level of customer care and a personal touch. Since launching in 2011, we’ve combined the personalized service of your neighborhood pet store with the convenience and speed of e-commerce. We pride ourselves on being the only brand available 24/7/365 to support pet parents throughout their journey. We have a rich history of being recognized for our deep care and personalization while going above and beyond for our customers and their pets. We view pets and their people as more than just customers and look forward to meeting their needs and exceeding expectations through every interaction. With Chewy, no one pet-parents alone. Our culture is for those who thrive on delivering results and becoming your best—no matter your role or location. At Chewy, our Operating Principles serve as a common language, or framework, that connects two of Chewy's most valuable elements—our people and our culture. The Operating Principles guide our character, capabilities, imagination, and methods for execution in support of our company's mission.
Cencora is a leading pharmaceutical solutions organization centered on improving the lives of people and animals everywhere. With 46,000+ global team members, we have the opportunity to make a positive impact on healthcare in communities everywhere. Our team members are empowered to activate their careers through a collective of tools and resources designed to support individual career interests and aspirations. We value our listening culture that actions real outcomes and our team members appreciate and recognize one another for contributions that are making a meaningful global impact. No matter what your role is here, the work we do together has meaning. When you join our team, you become a crucial part of a greater purpose. We’re committed to supporting you personally and professionally, so we can achieve more together at the center of health.
Galderma is the leading company solely dedicated to skin and advancing the future of dermatology. We deliver an innovative, science-based portfolio of sophisticated brands and services across Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology. Through trusted partnerships with healthcare professionals, we ensure to meet individual consumer and patient needs with superior outcomes.
LENUS BIOSCIENCE SPAC targets to acquire a conglomerate of companies in the area of medical cannabis CBD)
Chemical Information Services provides product-based information services to the global chemical and pharmaceutical buyer communities.
Pronounced /ree-AH-tah/ Reata Pharmaceuticals, Inc. (Nasdaq:RETA) is a clinical-stage biopharmaceutical company that develops novel therapeutics for patients with serious or life-threatening diseases by targeting molecular pathways involved in the regulation of cellular metabolism and inflammation. Reata’s two most advanced clinical candidates, bardoxolone methyl and omaveloxolone, target the important transcription factor Nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation.
At Senderra, Patients are people. It’s that simple. We are a specialty pharmacy, but that is where our work begins. We believe success lies in service to others. For this reason, we are dedicated to never losing sight of the people. We believe in the power of technology and data as catalysts to transform and improve processes. Technology is a tool to make our lives easier. For this reason, Senderra invests in our unique technology-driven platform in order to perform best at every turn. Finally, we believe in improved outcomes, no matter with whom we work. That includes Patients, Prescribers, Pharma and Payors. Improving outcomes means we strive to make the kinds of differences that matter.
Mentrik Biotech, LLC is a private biopharmaceutical company that was incorporated in December 2010 and is headquartered in Dallas, TX. The goal of Mentrik Biotech is to optimize oncology-based therapeutics to treat patients with significant unmet medical need.
Venturis Therapeutics, Inc. is a biopharmaceutical company developing protein drug candidates to address diseases such as diabetic wounds, severe coronary heart disease, and peripheral artery disease.
AlixaRx provides advanced pharmacy services to post‐acute healthcare facilities through a new model that leverages technology to deliver medication therapy management. AlixaRx is a differentiated approach because it utilizes a combination of clinical pharmacists, automated dispensing units, and electronic medication cabinets to meet the medical needs of patients and residents at each facility. AlixaRx delivers improved safety, creates better access to medications, and produces time and cost savings in post‐acute, skilled nursing, and numerous other healthcare settings.
OmniSYS is the only technology company exclusively focused on helping pharmacies grow. Our products help pharmacies communicate with patients, expand clinical services, and improve their financial performance.
Lantern Pharma, Inc. is a clinical stage pharmaceutical company developing new classes of precision cancer drugs with novel mechanisms of action, and also rescuing or revitalizing abandoned or failed cancer drugs using machine learning techniques, genomic data and precision oncology trials. Lantern Pharma recognizes that the high cost and low success rates in oncology drug development largely stem from the inability to appropriately stratify patient populations prior to enrollment, and also from the inability to fully elucidate mechanisms of action that can suggest potent combinations. Our approach which leverages our RADR platform helps to provide rapid, meaningful insight to both of these central problems in oncology. Lantern is focused on accelerating personalized cancer therapy development through the use of AI and genomic-based patient stratification.
Innox Digital is focused on developing augmented reality mobile applications for pharmaceutical products.
Peloton Therapeutics is translating groundbreaking scientific insights into first-in-class oral medicines to fight cancer and other serious conditions.
www.psgconsults.com. Pharmaceutical Strategies Group (PSG) is the leading pharmacy intelligence and technology company providing cutting-edge drug cost-management solutions. Drawing on more than 20 years of pharmaceutical innovation and best practices experience, we deploy proprietary technology, industry intelligence, data-enabled services and the industry’s most trusted advisors to help our clients reduce costs, enhance revenue, and optimize health outcomes. We offer a robust and holistic array of services designed to help healthcare systems, health plans, large employers and multi-employer organizations respond to the complexities of the prescription drug market and address their most pressing pharmacy management challenges. As a trusted strategic partner to more than 300 clients, we serve as an independent advocate and technology resource to help maximize their investment in pharmaceuticals. Our client-centric approach has allowed us maintain a 99.9 percent retention rate while generating over $6 billion in savings for organizations representing more than 100 million lives. Backed by a laser focus on pharmacy and unparalleled leverage in the marketplace, we deliver unbiased and actionable insights powered by analytics that enable us to ask better questions, find better answers and deliver better results.
Clinitiative Health Research™ stands at the forefront of the clinical research industry as a distinguished global consulting and business development organization based in the United States. Specializing in fostering strategic connections between premier independent clinical research sites and site networks with pharmaceutical sponsors and clinical research organizations (CROs), Clinitiative Health Research™ is committed to enhancing the success rate of research studies worldwide. By leveraging their vast expertise and industry knowledge, the organization streamlines the clinical trial process, ensuring that all stakeholders can navigate the complex world of research and development with confidence and efficiency. As a trusted partner in the realm of clinical research, Clinitiative Health Research™ plays a pivotal role in bridging the gap between pioneering clinical sites and pharmaceutical organizations, ultimately driving progress and innovation in the field of healthcare. Visit www.clinitiative.com to learn more.
DAVA Oncology was founded in 2007 with the goal of facilitating successful cancer drug development by providing innovative solutions and services to the pharmaceutical and biotechnology industries. DAVA has three business units - DAVA Clinical Trial Acceleration Services, Oncology Meeting Innovations and ONE Oncology. These business units accelerate clinical trial research timelines through MD-to-MD focused trial education, host non-CME scientific exchange programs across more than fifteen solid tumor and hematologic malignancies and create both custom and syndicated oncology education tools, respectively.
Dialectic Therapeutics is a biotechnology company which is created for innovative technologies to cure cancer.
We are a late-stage biopharmaceutical company focused on the development and commercialization of novel personalized therapeutics to treat cancer.
ICS, a business unit of AmerisourceBergen, partners with pharmaceutical manufacturers to deliver third-party logistics services that improve the quality and efficiency of their supply chains. As the pioneer in the specialty logistics market, ICS has helped bring hundreds of specialty pharmaceutical products to market and served as an integral component in their growth. ICS was founded in 1997 and since then, has organically grown to become the industry leader in outsourced logistics and distribution services for pharmaceutical manufacturers. From strategic program design to enhanced 3PL and performance analytics, ICS goes the extra mile to ensure increased supply chain efficiency, maximum return on investment and enhanced patient care. ICS is the model of excellence in global healthcare logistics.
Work Your Passion. Live Your Purpose.
